In the realm of modern pharmaceutical development, the precise synthesis of complex molecules is paramount. Advanced chemical intermediates serve as the foundational blocks for creating life-saving drugs. Among these critical compounds is a fascinating class of glucofuranose derivatives. Specifically, 1,2-O-(1-Methylethylidene)-3-O-(phenylmethyl)-α-D-glucofuranose (CAS 22529-61-9) has emerged as a pivotal player in the synthesis of important pharmaceuticals, most notably Fondaparinux Sodium. Understanding the utility and sourcing of such compounds is essential for manufacturers and researchers alike.

1,2-O-(1-Methylethylidene)-3-O-(phenylmethyl)-α-D-glucofuranose is a highly specialized carbohydrate derivative. Its intricate structure, with a molecular formula of C16H22O6 and a molecular weight of 310.34, makes it an ideal precursor for complex pharmaceutical applications. The compound is typically described as a clear, colorless to yellow oil, a physical characteristic that can influence its handling and reaction conditions in various synthetic processes. Its role as a Fondaparinux Sodium intermediate is particularly significant, as this drug is a synthetic pentasaccharide analogue of the biologically active pentasaccharide sequence of heparin, used for preventing and treating deep vein thrombosis.

The production and supply of such high-purity intermediates are critical for the pharmaceutical industry. Manufacturers seek reliable suppliers who can consistently provide chemicals that meet stringent quality standards. For companies looking to procure 1,2-O-(1-Methylethylidene)-3-O-(phenylmethyl)-α-D-glucofuranose, understanding the sourcing landscape, including key manufacturers and suppliers in regions like China, is a strategic advantage. The ability to purchase this intermediate in various quantities, from grams for research to larger amounts for production, ensures flexibility in research and development (R&D) and manufacturing operations.

Beyond its established role in Fondaparinux Sodium synthesis, this glucofuranose derivative also offers potential as a versatile building block for other complex organic synthesis projects. Researchers can explore its reactivity and structural features to design novel molecules with unique properties, expanding the scope of chemical innovation. By leveraging advanced chemical synthesis intermediates, the pharmaceutical sector can continue to drive progress in drug discovery and development, ultimately benefiting global health. For those engaged in pharmaceutical intermediate manufacturing, securing a consistent and high-quality supply of compounds like 1,2-O-(1-Methylethylidene)-3-O-(phenylmethyl)-α-D-glucofuranose is a cornerstone of successful operations.